APA

Moulis G., Sommet A., Lapeyre-Mestre M. & Montastruc J. (20150123). Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database. : Rheumatology (Oxford, England).

Chicago

Moulis Guillaume, Sommet Agnès, Lapeyre-Mestre Maryse and Montastruc Jean-Louis. 20150123. Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database. : Rheumatology (Oxford, England).

Harvard

Moulis G., Sommet A., Lapeyre-Mestre M. and Montastruc J. (20150123). Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database. : Rheumatology (Oxford, England).

MLA

Moulis Guillaume, Sommet Agnès, Lapeyre-Mestre Maryse and Montastruc Jean-Louis. Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database. : Rheumatology (Oxford, England). 20150123.